BDBM50103090 (4-{(S)-4-[(S)-1-(4-Benzo[1,3]dioxol-5-ylmethyl-phenyl)-ethyl]-3-methyl-piperazin-1-yl}-piperidin-1-yl)-o-tolyl-methanone::CHEMBL70124

SMILES C[C@H](N1CCN(C[C@@H]1C)C1CCN(CC1)C(=O)c1ccccc1C)c1ccc(Cc2ccc3OCOc3c2)cc1

InChI Key InChIKey=CWRFGTWBBWBDRR-UIOOFZCWSA-N

Data  1 KI  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50103090   

TargetMuscarinic acetylcholine receptor M2(Homo sapiens (Human))
Schering-Plough Research Institute

Curated by ChEMBL
LigandPNGBDBM50103090((4-{(S)-4-[(S)-1-(4-Benzo[1,3]dioxol-5-ylmethyl-ph...)
Affinity DataKi:  35nMAssay Description:Affinity for Muscarinic acetylcholine receptor M2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-C chemokine receptor type 5(Homo sapiens (Human))
Schering-Plough Research Institute

Curated by ChEMBL
LigandPNGBDBM50103090((4-{(S)-4-[(S)-1-(4-Benzo[1,3]dioxol-5-ylmethyl-ph...)
Affinity DataIC50:  90nMAssay Description:Ability of the compound to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed